ABCL
AbCellera Biologics Inc.
Late Extension, sector confirmed; strongest on insider signal (17/20); weakest on sponsorship (14/20). Last earnings neutral (-2.8%); 122% above the 200DMA.
Late Extension
XLV
sector confirmed
$529,596 CFO$1,968,179 other insiders (6)
4 insider(s)
net purchase ratio +1.00
10d since buy
79
conviction / 100
+0.2 since 24 Aug
77.1
technical / 100
$16,000–$20,000
Standard · sized down 60% for campaign stage (Late Extension)
Regime clarity17.0
Sponsorship / positioning14.0
Volatility behaviour16.0
Catalyst alignment (insider)17.3
Cross-asset confirmation14.7
Last
10.61
Add above
12.15
Cut below
5.09
50DMA
7.32
200DMA
4.79
ABCL — daily, 14 months
XLV — sector ETF, daily, 14 months
Pillar detail, thesis support and invalidation
Regime clarity
What strengthens the thesis
- price above 200DMA
- 200DMA rising
- 50DMA rising
- partial HH/HL structure
- efficiency ratio 0.22
- OBV 50d slope +0.318 avg-daily-volumes/bar
- price/volume history is NOT one continuous security — a single 35% session gap. A conversion, large secondary or stock merger changes the share count, so the 200DMA averages two capital structures and OBV sums two different securities. Read this pillar with suspicion.
- no OBV divergence at highs
- OBV fell through last pullback
- last pullback 11.7% deep
- no wide downside expansion bars (30d)
- ATR expanding vs 20d mean
- cluster: 4 distinct insiders buying (2 CFO, 4 Director, 2 Unclassified)
- net purchase ratio +1.00 (4 buying vs 0 selling)
- CFO purchases $529,596 (CFO)
- 1.5 bps of market cap
- grew the CFO's own position by 15%
- 10 days since the last CFO buy
- closest sector ETF: XLV
- XLV above rising 200DMA (sector-led)
- XLV vs SPY 6m: -1.3 pts
- stock vs XLV RS (3m/6m avg): +163.0 pts
- A confirmed higher high above 12.15 on expanding OBV.
- Pullbacks that hold the rising 50DMA with flat-to-rising OBV.
- XLV extending its own trend while the stock holds relative strength.
- Loss of the rising 50DMA (7.32) with expanding volatility — reduce.
- Breakdown below the prior structural base (5.09) — exit, no averaging down.
- OBV divergence during a price acceleration — reduce.
- Sector ETF losing its own 200DMA — remove capital regardless of stock behaviour.
- CFO: Booth Andrew — CFO
- 2 CFO purchase(s), $529,596 total; last filed 2026-08-14 12:04:25
- Market cap $3,451,104,256 · 20d avg dollar volume $95,837,374
Net buying across the insider group.
| Open-market purchases | $2,497,775 |
| Open-market sales | $0 |
| Sales after option exercise | $0 |
| Distinct buyers / sellers | 4 / 0 |
| Net purchase ratio | +1.00 |
| Net purchase ratio, excl. option-exercise sales | +1.00 |
2 CFO purchase(s) worth $529,596, plus 6 by other insiders worth $1,968,179. Only the CFO purchases score on the size and recency terms.
| Trade date | Insider | Shares | Price | Value | Price now vs buy |
|---|---|---|---|---|---|
| 26 Feb 2026 | Thermopylae Holdings Ltd.Unclassified | 177,457 | $3.27 | $580,284 | +224.5% |
| 27 Feb 2026 | Thermopylae Holdings Ltd.Unclassified | 38,000 | $3.44 | $130,720 | +208.4% |
| 27 Feb 2026 | Booth AndrewCFO | 42,600 | $3.42 | $145,692 | +210.2% |
| 14 May 2026 | Montalbano John S.Director | 20,000 | $4.77 | $95,400 | +122.4% |
| 12 Aug 2026 | Hayden Michael RDirector | 46,387 | $10.37 | $481,033 | +2.3% |
| 14 Aug 2026 | Booth AndrewCFO | 37,200 | $10.32 | $383,904 | +2.8% |
| 18 Aug 2026 | Montalbano John S.Director | 10,000 | $11.03 | $110,300 | -3.8% |
| 24 Aug 2026 | Hayden Michael RDirector | 53,613 | $10.64 | $570,442 | -0.3% |
8 material events; 2 taken well, 0 badly; last earnings 05 Aug: neutral (-2.8%).
| Session | Filing | Event | Gap | Day | vs SPY | Vol | +5d | Read |
|---|---|---|---|---|---|---|---|---|
| 13 Aug 26 | 8-K | Material agreement; Other material event | -0.3% | +5.9% | +5.2% | 2.5x | +5.5% | Rewarded |
| 10 Aug 26 | 8-K | Regulation FD disclosure | +26.4% | +34.8% | +34.8% | 9.0x | +19.9% | Neutral |
| 07 Aug 26 | 8-K | Other material event | +1.8% | +6.1% | +5.5% | 1.3x | +64.2% | Rewarded |
| 05 Aug 26 | 8-K · earnings | Results of operations (earnings); Regulation FD disclosure | -0.7% | -2.8% | -2.6% | 0.9x | +74.9% | Neutral |
| 05 Aug 26 | 10-Q | Quarterly report | -0.7% | -2.8% | -2.6% | 0.9x | +74.9% | Neutral |
| 29 Jul 26 | 8-K | Other material event | +0.9% | +1.9% | +3.4% | 0.9x | +9.8% | Neutral |
| 06 Jul 26 | 8-K | Director or officer change | -0.7% | -3.0% | -3.8% | 0.8x | -17.2% | Neutral |
| 17 Jun 26 | 8-K | Other material event | +2.3% | +6.9% | +8.1% | 0.8x | +22.4% | Neutral |